Christine R Talbott LCPC

Recommended Articles

• Why "I'll Push You" Is an Inspiring Film for Muscular Dystrophy Patients

  "I'll Push You" is a film that follows two friends who make the decision to take a journey lasting 500 miles.  For any set of friends, this would be intimidate, but these two friends aren't a normal pair.  Justin, one of the friends in the film, was diagnosed with a neuromuscular illness. The...

• What Is Nicotine?

  IntroductionNicotine is an alkaloid stimulant that comes from the nightshade family of plants, particularly from the leaves of tobacco. The type of nicotine found in tobacco plants is called Nicotiana tabacum. Nicotine can also be synthetically produced. Thousands of chemicals are contained in...

• Steroids for Multiple Sclerosis

  What is multiple sclerosis (MS)?Multiple sclerosis is a medical condition that affects the brain and the spinal cord. Some of the early symptoms of this disease include numbness, tingling sensations, blurry vision, and feeling weak. Individuals with MS also report other symptoms such as thinking...

• The Impact Marijuana Can Have on Type 2 Diabetes Patients

  Now more than ever, citizens across the nation and the world have begun to ponder the potential benefits of marijuana.  As the drug has been classified as a schedule 1 within the United States, research surrounding any potential benefits had been slowed.  With a growing interest in the proposed...

• What Is Polyuria?

  IntroductionPolyuria refers to frequent urination and passing excessive amounts of urine every time a person urinates. Normally, adults pass approximately 1-2 liters of urine per day. However, when there is an excessive urination volume of more than 3 liters a day, it is considered as...

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...